Radio-responsive recA promoter significantly increases TNFα production in recombinant clostridia after 2 Gy irradiation

被引:93
作者
Nuyts, S
Van Mellaert, L
Theys, J
Landuyt, W
Bosmans, E
Anné, J
Lambin, P
机构
[1] Univ Hosp Gasthuisberg, Lab Expt Radiobiol, Louvain, Belgium
[2] DiaMed Eurogen, Tessenderlo, Belgium
[3] Univ Maastricht, Acad Hosp Maastricht, Dept Radiat Oncol, RTIL, Maastricht, Netherlands
[4] Katholieke Univ Leuven, Rega Inst, Bacteriol Lab, B-3000 Louvain, Belgium
关键词
Clostridium; radio-inducible promoter; radiotherapy; recA; TNF alpha;
D O I
10.1038/sj.gt.3301499
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the major problems with gene therapy today is the lack of tumour specificity. The use of anaerobic apathogenic clostridia as a gene transfer system can target anoxic areas within the tumour. These bacteria can be genetically modified to express therapeutic proteins such as TNF alpha locally in the tumour. As shown in our results, ionising irradiation can be used in clostridia to activate genes encoding cytotoxic agents under control of a radiation-inducible promoter. A 44% significant increase (P < 0.05) in TNF<alpha> secretion was seen 3.5 h after a single dose of 2 Gy. A second dose of 2 Gy was also capable of repeating gene activation and gave a significant increase of TNF alpha production of 42% (P < 0.05). These results provide evidence that spatial and temporal control of gene expression can be achieved using a radio-inducible promoter. Repetitive gene activation was feasible with a second dose of 2 Gy, indicating that fractionated radiotherapy could lead to repeated gene induction resulting in prolonged and enhanced protein expression. Gene targeting by ionising radiation could thus provide a new means of increasing the therapeutic ratio in cancer treatment.
引用
收藏
页码:1197 / 1201
页数:5
相关论文
共 32 条
[1]  
Fox ME, 1996, GENE THER, V3, P173
[2]   THE INTERACTION BETWEEN RECOMBINANT HUMAN TUMOR-NECROSIS-FACTOR AND RADIATION IN 13 HUMAN TUMOR-CELL LINES [J].
HALLAHAN, DE ;
BECKETT, MA ;
KUFE, D ;
WEICHSELBAUM, RR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 19 (01) :69-74
[3]   SPATIAL AND TEMPORAL CONTROL OF GENE-THERAPY USING IONIZING-RADIATION [J].
HALLAHAN, DE ;
MAUCERI, HJ ;
SEUNG, LP ;
DUNPHY, EJ ;
WAYNE, JD ;
HANNA, NN ;
TOLEDANO, A ;
HELLMAN, S ;
KUFE, DW ;
WEICHSELBAUM, RR .
NATURE MEDICINE, 1995, 1 (08) :786-791
[4]   Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir [J].
Joki, T ;
Nakamura, M ;
Ohno, T .
HUMAN GENE THERAPY, 1995, 6 (12) :1507-1513
[5]   Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation [J].
Kawashita, Y ;
Ohtsuru, A ;
Kaneda, Y ;
Nagayama, Y ;
Kawazoe, Y ;
Eguchi, S ;
Kuroda, H ;
Fujioka, H ;
Ito, M ;
Kanematsu, T ;
Yamashita, S .
HUMAN GENE THERAPY, 1999, 10 (09) :1509-1519
[6]   Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours [J].
Lambin, P ;
Theys, J ;
Landuyt, W ;
Rijken, P ;
van der Kogel, A ;
van der Schueren, E ;
Hodgkiss, R ;
Fowler, J ;
Nuyts, S ;
de Bruijn, E ;
Van Mellaert, L ;
Anne, J .
ANAEROBE, 1998, 4 (04) :183-188
[7]   CYTOTOXIC MECHANISM OF TUMOR-NECROSIS-FACTOR-ALPHA [J].
LARRICK, JW ;
WRIGHT, SC .
FASEB JOURNAL, 1990, 4 (14) :3215-3223
[8]   Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment [J].
Lemmon, MJ ;
vanZijl, P ;
Fox, ME ;
Mauchline, ML ;
Giaccia, AJ ;
Minton, NP ;
Brown, JM .
GENE THERAPY, 1997, 4 (08) :791-796
[9]   Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter:: Activation by ionizing radiation or uptake of radioactive iododeoxyuridine [J].
Manome, Y ;
Kunieda, T ;
Wen, PY ;
Koga, T ;
Kufe, DW ;
Ohno, T .
HUMAN GENE THERAPY, 1998, 9 (10) :1409-1417
[10]   Development of synthetic promoters for radiation-mediated gene therapy [J].
Marples, B ;
Scott, SD ;
Hendry, JH ;
Embleton, MJ ;
Lashford, LS ;
Margison, GP .
GENE THERAPY, 2000, 7 (06) :511-517